Browsing by Author "Kurt, E."

Filter results by typing the first few letters
Now showing 1 - 3 of 3
  • No Thumbnail Available
    Publication
    Confidence intervals for proportions - the cinderella of statistical analyses - response
    (Elsevier Science London, 2008-02-01) Kanat, O.; Yalçınkaya, U.; Akbunar, T.; Kurt, E.; Evrensel, T.; Manavoğlu, O.; Kanat, O.; YALÇINKAYA, ÜLVİYE; Akbunar, T.; Kurt, Ender; EVRENSEL, TÜRKKAN; Manavoğlu, Osman; Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı.; Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı.; Uludağ Üniversitesi/Tıp Fakültesi/Nükleer Tıp Anabilim Dalı.; AAJ-1027-2021; AAH-8924-2021; CWN-8579-2022; EKU-8682-2022; DAS-3088-2022; FLP-9613-2022
  • Thumbnail Image
    Item
    Does the change in body mass index during induction chemo/ chemoradiotherapy affect the outcome of surgery in locally advanced NSCLC
    (Elsevier, 2018-10) Özer, Erhan; Çetinkaya, Gamze; Deligönul, Adem; Melek, Hüseyin; Sevinç, Tayhan; Kurt, E.; Bayram, Ahmet Sami; Evrensel, Türkkan; Gebitekin, Cengiz; Uludağ Üniversitesi/Tıp Fakültesi/Tıbbi Onkoloji Anabilim Dalı.; Uludağ Üniversitesi/Tıp Fakültesi/Göğüs Cerrahisi.; 0000-0002-4848-1566; 0000-0003-0684-0900; 0000-0002-9732-5340; 0000-0003-1822-8153; JDW-2654-2023; ABB-7580-2020; AAJ-1027-2021; JCE-0097-2023; AAI-5039-2021; AAE-1069-2022
  • No Thumbnail Available
    Publication
    Prognostic significance of estrogen receptor, progesterone receptor, her2/neu, ki-67, and nm23 expression in patients with invasive breast cancer
    (Imprimatur Publications, 2013-04-01) Ölmez, F.; Çubukçu, E.; ÇUBUKÇU, ERDEM; DELİGÖNÜL, ADEM; Kanat, O.; Ölmez, O. Fatih; Kabul, S.; KABUL, SELVA; Canhoroz, M.; Avcı, N.; Deligönül, A.; Hartavi, M.; Çubukçu, S.; ÇUBUKÇU, SİNEM; Kurt, E.; Evrensel, T.; EVRENSEL, TÜRKKAN; Gökgöz, S.; GÖKGÖZ, MUSTAFA ŞEHSUVAR; Manavoğlu, O.; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Onkoloji Anabilim Dalı.; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Genel Cerrahi Anabilim Dalı.; Bursa Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı.; AAJ-1027-2021
    Purpose: To determine the prognostic significance of estrogen receptor (ER), progesterone receptor (PR), HER2/neu, Ki-67, and nm23 immunohistochemical expression with respect to progression free survival (PFS) and overall survival (OS) in Turkish patients with invasive breast cancer (IBC).Methods: Patients with IBC (n = 81; mean age = 51.9 +/- 11.1 years) were prospectively enrolled at the Department of Oncology, Uludag University Medical Center, Bursa, Turkey. Immunohistochemistry was performed on formalin-fixed, paraffin-embedded tissue sections.Results: We did not find any significant association between immunohistochemical expression of ER, PR, HER2/neu, Ki-67, and nm23 and the baseline characteristics of IBC patients. The median patient PFS was 30 months (range 22-45), and the median OS was 32 months (range 23-46). Stratification of the patient population according to nm23 immunohistochemical expression revealed a statistically significant difference in terms of both OS (p < 0.05) and DFS (p < 0.05). Multivariate Cox regression analysis indicated that tumor grade, axillary lymph node status, and nm23 immunohistochemical expression were the 3 main independent prognostic factors for PFS and OS in IBC patients.Conclusion: Reduced nm23 immunohistochemical expression is an independent negative prognostic factor for OS and PFS. Patients with negative nm23 expression may require a more intensive follow-up.